✦ LIBER ✦

Choice of starting dose and escalation for phase I studies of antitumor agents

✍ Scribed by John S. Penta; Gary L. Rosner; Donald L. Trump

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adaptive designs for dual-agent phase I

✍ Harrington, Jennifer A.; Wheeler, Graham M.; Sweeting, Michael J.; Mander, Adria 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 498 KB

Mouse and large-animal toxicology studie

✍ J. S. Penta; M. Rozencweig; A. M. Guarino; F. M. Muggia 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 399 KB

Phase I Dose Escalation of Single-Agent

✍ D.B. Bailey; K.M. Rassnick; O. Kristal; J.D. Chretin; C.E. Balkman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Phase I Dose Escalation Study of Sunitin

✍ Chung, C.; Menard, C.; Stevens, C.; Laperriere, N.; Millar, B.; Bernstein, M.; Z 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Phase I Dose-escalation Study of (SBRT)

✍ Ghaly, M.; Marrero, M.; Vijeh, L.; Montchal, E.; Lee, L.; Potters, L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase I dose escalation study of tumor n

✍ Dennis E. Hallahan; R.R. Weichselbaum; S.J. Rubin; S. Vijaykumar; B. Samuels; R. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 135 KB